Stockreport

XORTX Announces Results from Mount Sinai’s COVID-19 Clinical Study

XORTX Therapeutics Inc.  (XRTX) 
PDF CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company [Read more]